BIOMARKERS FOR DIABETES COMPLICATIONS: THE RESULTS OF SEVERAL CLINICAL STUDIES

被引:9
作者
Aslan, Diler [1 ]
机构
[1] Pamukkale Univ, Sch Med, Dept Med Biochem, Denizli, Turkey
关键词
diabetes; biomarkers; clinical studies; HEPATOCYTE GROWTH-FACTOR; URINARY BIOMARKERS; GENE POLYMORPHISMS; OXIDATIVE STRESS; DISEASE; ASSOCIATION; MELLITUS; RISK; NEPHROPATHY; MORTALITY;
D O I
10.2478/v10011-011-0024-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetes is a common metabolic disorder. Its microvascular and macrovascular complications contribute to death, disabilities, and reduction in life expectancy in diabetes. It is a costly disease, and affects not only the patient and family, but also the public health, communities and society. It takes an increasing proportion of the national health care expenditure. The prevention of the development of diabetes and its complications is a major concern. Biomarkers have been investigated for understanding the mechanisms of the development and progression of diabetic complications. In this paper, the biomarkers which are recommended in the clinical practice and laboratory medicine guidelines, and which have been investigated for prediction or diagnosis of diabetes complications, have been reviewed. The results of several clinical studies will be summarized.
引用
收藏
页码:207 / 212
页数:6
相关论文
共 61 条
[21]   Association between PON 1 polymorphisms, PON activity and diabetes complications [J].
Hofer, Sabine E. ;
Bennetts, Bruce ;
Chan, Albert K. ;
Holloway, Bethwyn ;
Karschlmkus, Connie ;
Jenkins, Alicia J. ;
Silink, Martin ;
Donaghue, Kim C. .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2006, 20 (05) :322-328
[22]   Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes [J].
Jaziri, Riphed ;
Aubert, Roberte ;
Roussel, Ronan ;
Emery, Nathalie ;
Maimaitiming, Suliya ;
Bellili, Naiema ;
Miot, Aurelie ;
Saulnier, Pierre-Jean ;
Travert, Florence ;
Hadjadj, Samy ;
Marre, Michel ;
Fumeron, Frederic .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (07) :2231-2237
[23]   SLC2A10 genetic polymorphism predicts development of peripheral arterial disease in patients with type 2 diabetes. SLC2A10 and PAD in type 2 diabetes [J].
Jiang, Yi-Der ;
Chang, Yi-Cheng ;
Chiu, Yen-Feng ;
Chang, Tien-Jyun ;
Li, Hung-Yuan ;
Lin, Wen-Hsing ;
Yuan, Hsiang-Yu ;
Chen, Yuan-Tsong ;
Chuang, Lee-Ming .
BMC MEDICAL GENETICS, 2010, 11
[24]   The Role of Inflammatory Cytokines in Diabetes and Its Complications [J].
King, George L. .
JOURNAL OF PERIODONTOLOGY, 2008, 79 (08) :1527-1534
[25]   Development of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort [J].
Kolberg, Janice A. ;
Jorgensen, Torben ;
Gerwien, Robert W. ;
Hamren, Sarah ;
McKenna, Michael P. ;
Moler, Edward ;
Rowe, Michael W. ;
Urdea, Mickey S. ;
Xu, Xiaomei M. ;
Hansen, Torben ;
Pedersen, Oluf ;
Borch-Johnsen, Knut .
DIABETES CARE, 2009, 32 (07) :1207-1212
[26]   Relationships among Diabetic Retinopathy, Antioxidants, and Glycemic Control [J].
Lam, Carly S. Y. ;
Benzie, Iris F. F. ;
Choi, Siu Wai ;
Chan, Lily Y. L. ;
Yeung, Vincent T. F. ;
Woo, George C. .
OPTOMETRY AND VISION SCIENCE, 2011, 88 (02) :251-256
[27]   Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes [J].
Lin, J. ;
Hu, F. B. ;
Mantzoros, C. ;
Curhan, G. C. .
DIABETOLOGIA, 2010, 53 (02) :263-267
[28]   The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study [J].
Lu, Tse-Min ;
Lin, Shing-Jong ;
Lin, Ming-Wei ;
Hsu, Chiao-Po ;
Chung, Ming-Yi .
CARDIOVASCULAR DIABETOLOGY, 2011, 10
[29]   Genetic Variants of the Protein Kinase C-β1 Gene and Development of End-Stage Renal Disease in Patients With Type 2 Diabetes [J].
Ma, Ronald C. W. ;
Tam, Claudia H. T. ;
Wang, Ying ;
Luk, Andrea O. ;
Hu, Cheng ;
Yang, Xilin ;
Lam, Vincent ;
Chan, Alfred W. H. ;
Ho, Janice S. K. ;
Chow, Chun-Chung ;
Tong, Peter C. Y. ;
Jia, Weiping ;
Ng, Maggie C. Y. ;
So, Wing-Yee ;
Chan, Juliana C. N. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (08) :881-889
[30]   Personalized Medicine in Diabetes [J].
Malandrino, Noemi ;
Smith, Robert J. .
CLINICAL CHEMISTRY, 2011, 57 (02) :231-240